Skip to main content
. Author manuscript; available in PMC: 2017 Feb 1.
Published in final edited form as: Hypertension. 2015 Nov 30;67(2):294–300. doi: 10.1161/HYPERTENSIONAHA.115.05949

Table 3.

Associations of each adipokine with transformed CFPWV (−1000/CFPWV)

Model 1* Model 2 Model 3§
Adipokine Regression coefficient. per SD (95%CI) P Value Regression coefficient. per SD (95%CI) P Value Regression coefficient. per SD (95%CI) P Value
RBP4 0.58 (−0.08,1.23) 0.09 0.60 (−0.06,1.25) 0.08 0.58 (−0.08,1.25) 0.09
A-FABP 1.14 (0.54,1.73) 0.0002 0.96 (0.25,1.67) 0.008 0.88 (0.16,1.60) 0.02
Leptin −0.03 (−0.70,0.64) 0.93 −1.06 (−1.95,−0.18) 0.02 −1.22 (−2.12,−0.32) 0.008
LEP-R −0.79 (−1.35,−0.24) 0.005 −0.65 (−1.21,−0.08) 0.02 −0.65 (−1.21,−0.08) 0.03
Adiponectin 0.22 (−0.54,0.97) 0.57 0.38 (−0.40,1.15) 0.34 0.47 (−0.31,1.25) 0.24

Beta coefficient per standard deviation (SD) of sex standardized biomarkers as in Table 1.

*

Model 1: adjusted for age, sex, heart rate, height, anti-hypertensive treatment, total and HDL cholesterol, smoking, diabetes and mean arterial pressure.

Model 2: adjusted for Model 1 covariates and body weight.

§

Model 3: adjusted for Model 2 covariates plus estimated glomerular filtration, alcohol, glucose, log transformed c reactive protein.

Abbreviations: LEP-R- leptin receptor, A-FABP- fatty acid binding protein 4, RBP4- retinol binding protein 4, CFPWVcarotid femoral pulse wave velocity, m/s- meters per second